Form 8-K - Current report:
SEC Accession No. 0001698530-22-000042
Filing Date
2022-06-29
Accepted
2022-06-29 17:06:09
Documents
15
Period of Report
2022-06-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20220629.htm   iXBRL 8-K 50594
2 EX-3.1 ex31-certificateofamendmen.htm EX-3.1 13669
3 EX-99.1 ex991_pressreleasedated062.htm EX-99.1 12348
7 exicureimage1a10a.gif GRAPHIC 2794
  Complete submission text file 0001698530-22-000042.txt   238084

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20220629.xsd EX-101.SCH 1905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20220629_lab.xml EX-101.LAB 25832
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20220629_pre.xml EX-101.PRE 13580
9 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20220629_htm.xml XML 11859
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 221055428
SIC: 2834 Pharmaceutical Preparations